AbCellera appoints Neil Aubuchon as Chief Commercial Officer

AbCellera Biologics Inc.

Neil Aubuchon named CCO effective December 2, 2021; will lead commercial strategy and partnership evaluation.
Aubuchon brings over 20 years experience from Amgen, Lilly, and Santen, including global marketing roles.
CEO Carl Hansen cited Aubuchon's commercial experience as key to expanding AbCellera's deal structures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.